The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · see citing works

Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082 · see citing works

Association of attention-deficit disorder and the dopamine transporter gene.

Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & LEVENTHAL, B. L. (1995) · PubMed Central · Cited by 990 · see citing works

Trace amines: Identification of a family of mammalian G protein-coupled receptors

Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912 · see citing works

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872 · see citing works

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle

SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830 · see citing works

Dopamine transporter density in patients with attention deficit hyperactivity disorder

Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684 · see citing works

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681 · see citing works

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666 · see citing works

Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor

Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651 · see citing works

Cloning and Expression of a Cocaine-Sensitive Rat Dopamine Transporter

Kilty, J. E., Lorang, D., & Amara, S. (1991) · Science · doi:10.1126/science.1948035 · Cited by 597 · see citing works

The dopamine transporter: immunochemical characterization and localization in brain

Ciliax, B. J., Heilman, C. J., Demchyshyn, L. L., Pristupa, Z. B., Ince, E., Hersch, S. M., Niznik, H. B., & Levey, A. I. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01714.1995 · Cited by 589 · see citing works

Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder

Sowell, E. R., Thompson, P. M., Welcome, S. E., Henkenius, A. L., Toga, A. W., & Peterson, B. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14842-8 · Cited by 567 · see citing works

Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum

Heinz, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00099-8 · Cited by 538 · see citing works

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

Krause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521 · see citing works

Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder

Biederman, J., & Spencer, T. J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00192-4 · Cited by 513 · see citing works

Monoamine transporters and psychostimulant drugs.

Rothman, R., & Baumann, M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.054 · Cited by 509 · see citing works

American Medical Association Council on Scientific Affairs

Goodman, C. S. (1988) · Cited by 496 · see citing works

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.

Gill, M., Daly, G., Heron, S., Hawi, Z., & Fitzgerald, M. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000290 · Cited by 482 · see citing works

The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons

Nirenberg, M. J., Vaughan, R., Uhl, G. R., Kuhar, M. J., & Pickel, V. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00436.1996 · Cited by 481 · see citing works

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

BIEDERMAN, J., WILENS, T., MICK, E., FARAONE, S. V., WEBER, W., CURTIS, S., THORNELL, A., PFISTER, K., JETTON, J. G., & SORIANO, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199701000-00013 · Cited by 476 · see citing works

Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices

Heikkila, R. E., Orlansky, H., & Cohen, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90152-5 · Cited by 468 · see citing works

Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants

Lambert, N. M., & Hartsough, C. S. (1998) · Journal of Learning Disabilities · doi:10.1177/002221949803100603 · Cited by 465 · see citing works

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity

Waldman, I. D., Rowe, D. C., Abramowitz, A., Kozel, S. T., Mohr, J. H., Sherman, S. L., Cleveland, H. H., Sanders, M. L., Gard, J. M. C., & Stever, C. (1998) · The American Journal of Human Genetics · doi:10.1086/302132 · Cited by 462 · see citing works

Multiple Ionic Conductances of the Human Dopamine Transporter: The Actions of Dopamine and Psychostimulants

Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., & Amara, S. G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00960.1997 · Cited by 446 · see citing works

Catecholamines in Attention-Deficit Hyperactivity Disorder: Current Perspectives

Pliszka, S. R., McCracken, J. T., & Maas, J. W. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199603000-00006 · Cited by 440 · see citing works

The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression

Fuke, S., Suo, S., Takahashi, N., Koike, H., Sasagawa, N., & Ishiura, S. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500026 · Cited by 415 · see citing works

Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children

Daly, G., Hawi, Z., Fitzgerald, M., & Gill, M. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000510 · Cited by 414 · see citing works

Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals

Carboni, E., Tanda, G., Frau, R., & Chiara, G. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04599.x · Cited by 412 · see citing works

Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism

Saunders, C., Ferrer, J. V., Shi, L., Chen, J., Merrill, G. A., Lamb, M. E., Leeb-Lundberg, L. M. F., Carvelli, L., Javitch, J. A., & Galli, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110035297 · Cited by 410 · see citing works

Monoamine Transporters: From Genes to Behavior

Gainetdinov, R. R., & Caron, M. G. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.050802.112309 · Cited by 394 · see citing works

Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action

Sulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389 · see citing works

A review of the biological bases of ADHD: What have we learned from imaging studies?

Durston, S. (2003) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10079 · Cited by 388 · see citing works

Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.

Raiteri, M., Cerrito, F., Cervoni, A. M., & Levi, G. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31548-x · Cited by 383 · see citing works

Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.

Gu, H., Wall, S. C., & Rudnick, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37256-3 · Cited by 379 · see citing works

DAncing past the DAT at a DA synapse

Cragg, S. J., & Rice, M. E. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.011 · Cited by 373 · see citing works

Attention-deficit/hyperactivity disorder: a life-span perspective.

Biederman, J. (1998) · PubMed · Cited by 361 · see citing works

Mechanism of action of methylphenidate: Insights from PET imaging studies

Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s05 · Cited by 353 · see citing works

Regulated Trafficking of the Human Dopamine Transporter

Daniels, G. M., & Amara, S. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35794 · Cited by 352 · see citing works

Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization

Lewis, D. A., Melchitzky, D. S., Sesack, S. R., Whitehead, R. E., Auh, S., & Sampson, A. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1092 · Cited by 352 · see citing works

Neurobiology of Attention Deficit Disorder With Hyperactivity: Where Have We Come in 50 Years?

Zametkin, A. J., & Rapoport, J. L. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198709000-00011 · Cited by 348 · see citing works

Functional Interaction between Monoamine Plasma Membrane Transporters and the Synaptic PDZ Domain–Containing Protein PICK1

Torres, G. E., Yao, W.-D., Mohn, A. R., Quan, H., Kim, K.-M., Levey, A. I., Staudinger, J. L., & Caron, M. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00267-7 · Cited by 344 · see citing works

Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR

Mill, J., Asherson, P., Browes, C., D'Souza, U., & Craig, I. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.b.10948 · Cited by 341 · see citing works

Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters.

Bruno Giros, A., Wang, Y. M., Suter, S. E., McLeskey, S. B., Pifl, C., & Caron, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33961-3 · Cited by 322 · see citing works

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Franceschi, D., Maynard, L., Ding, Y., Gatley, S. J., Gifford, A., Zhu, W., et al. (2002) · Synapse · doi:10.1002/syn.10038 · Cited by 321 · see citing works

Striatal dopamine transporters and cognitive functioning in healthy men and women

Mozley, L. H., Gur, R. C., Mozley, P. D., & Gur, R. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1492 · Cited by 314 · see citing works

Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?

Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294 · see citing works

Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors

Kahn, R. S., Khoury, J. C., Nichols, W. C., & Lanphear, B. P. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00208-7 · Cited by 284 · see citing works

Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1.

Comings, D., Wu, S., Chiu, C., Ring, R., Gade, R., Ahn, C., MacMurray, J. P., Dietz, G., & Muhleman, D. (1996) · American journal of medical genetics · doi:10.1002/(sici)1096-8628(19960531)67:3 · Cited by 283 · see citing works

Oligomerization and Trafficking of the Human Dopamine Transporter

Torres, G. E., Carneiro, A. M. D., Seamans, K., Fiorentini, C., Sweeney, A., Yao, W., & Caron, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m201926200 · Cited by 278 · see citing works

Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment

Dresel, S., Krause, J., Krause, K.-H., LaFougere, C., Brinkbäumer, K., Kung, H. F., Hahn, K., & Tatsch, K. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000330 · Cited by 278 · see citing works

Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report

Jacobsen, L. K., Staley, J. K., Zoghbi, S. S., Seibyl, J. P., Kosten, T. R., Innis, R. B., & Gelernter, J. E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1700 · Cited by 277 · see citing works

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

Singer, H. S., Hahn, I., & Moran, T. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300408 · Cited by 273 · see citing works

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND COMORBIDITY

Spencer, T. J., Biederman, J., & Wilens, T. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70163-2 · Cited by 271 · see citing works

Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood

Bolaños, C. A., Barrot, M., Berton, O., Wallace-Black, D., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00570-5 · Cited by 267 · see citing works

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues

Wilens, T. E. (2004) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00113-8 · Cited by 264 · see citing works

The Dopamine Transporter Constitutively Internalizes and Recycles in a Protein Kinase C-regulated Manner in Stably Transfected PC12 Cell Lines

Loder, M. K., & Melikian, H. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301845200 · Cited by 255 · see citing works

Anti-hyperactivity medication: methylphenidate and amphetamine

Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252 · see citing works

Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane.

Madras, B. K., Spealman, R. D., Fahey, M. A., Neumeyer, J. L., Saha, J. K., & Milius, R. A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09647-6 · Cited by 250 · see citing works

Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: Proof-of-Concept and Proof-of-Product Studies

Swanson, J., Gupta, S., Lam, A., Shoulson, I., Lerner, M., Modi, N., Lindemulder, E., & Wigal, S. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.204 · Cited by 248 · see citing works

Enduring behavioral effects of early exposure to methylphenidate in rats

Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248 · see citing works

Association of the Dopamine Transporter Gene (DAT1) With Poor Methylphenidate Response

Winsberg, B. G., & Comings, D. E. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199912000-00006 · Cited by 245 · see citing works

Dopamine transporter–mediated conductances increase excitability of midbrain dopamine neurons

Ingram, S., Prasad, B. M., & Amara, S. (2002) · Nature Neuroscience · doi:10.1038/nn920 · Cited by 235 · see citing works

Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression

Miller, G. M., & Madras, B. K. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000921 · Cited by 230 · see citing works

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach

Breier, A., Adler, C. M., Weisenfeld, N., Su, T.-P., Elman, I., Picken, L., Malhotra, A. K., & Pickar, D. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199806)29:2 · Cited by 226 · see citing works

Stimulant drugs and ADHD : basic and clinical neuroscience

Solanto, M. V., Arnsten, A. F. T., & Castellanos, F. X. (2001) · Cited by 223 · see citing works

[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

Malison, R. T., McDougle, C. J., van Dyck, C. H., Scahill, L. D., Baldwin, R. M., Seibyl, J. P., Price, L. H., Leckman, J. F., & Innis, R. B. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1359 · Cited by 223 · see citing works

A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs

Vandenbergh, D. J., Persico, A. M., & Uhl, G. R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90165-8 · Cited by 222 · see citing works

Characteristics of Drug Interactions with Recombinant Biogenic Amine Transporters Expressed in the Same Cell Type

Eshleman, A. J., Carmolli, M., Cumbay, M. G., Martens, C. R., Neve, K. A., & Janowsky, A. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38214-x · Cited by 219 · see citing works

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children*

Swanson, J., Gupta, S., Guinta, D., Flynn, D., Agler, D., Lerner, M., Williams, L., Shoulson, I., & Wigal, S. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70038-x · Cited by 216 · see citing works

Dendrodendritic Inhibition Through Reversal of Dopamine Transport

Falkenburger, B. H., Barstow, K. L., & Mintz, I. M. (2001) · Science · doi:10.1126/science.1060645 · Cited by 214 · see citing works

Cocaine Increases Dopamine Uptake and Cell Surface Expression of Dopamine Transporters

Daws, L. C., Callaghan, P. D., Morón, J. A., Kahlig, K. M., Shippenberg, T. S., Javitch, J. A., & Galli, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6384 · Cited by 208 · see citing works

The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons

Michelhaugh, S. K., FISKERSTRAND, C. E., Lovejoy, E. A., Bannon, M. J., & Quinn, J. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00647.x · Cited by 199 · see citing works

A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.

Wong, D. T., Threlkeld, P. G., Best, K. L., & Bymaster, F. P. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33153-8 · Cited by 194 · see citing works

The Variable Number of Tandem Repeats Polymorphism of the Dopamine Transporter Gene Is Not Associated with Significant Change in Dopamine Transporter Phenotype in Humans

Martinez, D., Gelernter, J., Abi-Dargham, A., van Dyck, C., Kegeles, L., Innis, R., & Laruelle, M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00216-5 · Cited by 193 · see citing works

Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder

Biederman, J., & Faraone, S. V. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s03 · Cited by 192 · see citing works

Oligomerization of Dopamine Transporters Visualized in Living Cells by Fluorescence Resonance Energy Transfer Microscopy

Sorkina, T., Doolen, S., Galperin, E., Zahniser, N. R., & Sorkin, A. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210652200 · Cited by 192 · see citing works

The Role of N-Glycosylation in Function and Surface Trafficking of the Human Dopamine Transporter

Li, L., Chen, N., Ramamoorthy, S., Chi, L., Cui, X., Wang, L. C., & Reith, M. E. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311972200 · Cited by 189 · see citing works

Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder

Cheon, K.-A. A., Ryu, Y. H., Kim, Y.-K., Namkoong, K., Kim, C., & Lee, J. E. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1047-3 · Cited by 187 · see citing works

Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats

Shoblock, J. R., Sullivan, E. B., Maisonneuve, I. M., & Glick, S. D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1288-7 · Cited by 181 · see citing works

Dynamic regulation of the dopamine transporter

Mortensen, O. V., & Amara, S. G. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.066 · Cited by 181 · see citing works

The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder

Krause, K.-H., Dresel, S. H. J., Krause, J., la Fougère, C. J., & Ackenheil, M. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.012 · Cited by 181 · see citing works

Stimulant Drugs and ADHD: Basic and Clinical Neuroscience

Durant, N. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1959-a · Cited by 180 · see citing works

Cocaine Induction of Dopamine Transporter Trafficking to the Plasma Membrane

Little, K. Y., Elmer, L. W., Zhong, H., Scheys, J. O., & Zhang, L. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.2.436 · Cited by 175 · see citing works

Serum and brain concentrations of methylphenidate: implications for use and abuse

Swanson, J. M., & Volkow, N. D. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.013 · Cited by 173 · see citing works

Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.

Melikian, H. E., Ramamoorthy, S., Tate, C. G., & Blakely, R. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09218-1 · Cited by 171 · see citing works

Attention‐deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene

Roman, T., Schmitz, M. D., Polanczyk, G. V., Eizirik, M., Rohde, L. A., & Hutz, M. H. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1408 · Cited by 171 · see citing works

α‐Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease

Sidhu, A., Wersinger, C., & Vernier, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.063 · Cited by 170 · see citing works

Functional Effects of the DAT1 Polymorphism on EEG Measures in ADHD

Loo, S. K., SPECTER, E., Smolen, A., Hopfer, C. J., Teale, P. D., & Reite, M. L. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046890.27264.88 · Cited by 169 · see citing works

Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder

Barr, C. L., Xu, C., Kroft, J., Feng, Y., Wigg, K. G., Zai, G. C., Tannock, R., Schachar, R. J., MALONE, M. A., Roberts, W., et al. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01053-2 · Cited by 166 · see citing works

Trace amine receptors as targets for novel therapeutics: legend, myth and fact

Branchek, T. A., & Blackburn, T. P. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00028-0 · Cited by 163 · see citing works

Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples

Curran, S. R., Mill, J. S., Tahir, E., Kent, L., Richards, S., Gould, A., Huckett, L., Sharp, J., Batten, C., Fernando, S., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000914 · Cited by 162 · see citing works

Dopamine genes and attention-deficit hyperactivity disorder: a review

DiMaio, S., Grizenko, N., & Joober, R. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0303 · Cited by 153 · see citing works

Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD

Kirley, A., Lowe, N., Hawi, Z., Mullins, C., Daly, G., Waldman, I. D., McCarron, M., O'Donnell, D., Fitzgerald, M., & Gill, M. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20071 · Cited by 151 · see citing works

Early Methylphenidate Administration to Young Rats Causes a Persistent Reduction in the Density of Striatal Dopamine Transporters

Moll, G. H., Hause, S., Rüther, E., Rothenberger, A., & Huether, G. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750143366 · Cited by 147 · see citing works

A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder

Holmes, J., Payton, A., Barrett, J. H., Hever, T., Fitzpatrick, H., Trumper, A., Harrington, R., McGuffin, P., Owen, M. J., Ollier, W., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000751 · Cited by 146 · see citing works

Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder

van Dyck, C. H., Quinlan, D. M., Cretella, L. M., Staley, J. K., Malison, R. T., Baldwin, R. M., Seibyl, J. P., & Innis, R. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.309 · Cited by 139 · see citing works

Attention-Deficit/Hyperactivity Disorder and Substance Use: Symptom Pattern and Drug Choice

Clure, C. L., Brady, K. T., Saladin, M. E., Johnson, D. E., Waid, R., & Rittenbury, M. (1999) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-100101871 · Cited by 135 · see citing works

Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use

Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135 · see citing works

Regulation of the Vesicular Monoamine Transporter-2: A Novel Mechanism for Cocaine and Other Psychostimulants

Brown, J. M., Hanson, G. R., & Fleckenstein, A. E. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38814-7 · Cited by 135 · see citing works

Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function

Fleckenstein, A. E., Haughey, H. M., Metzger, R. R., Kokoshka, J. M., Riddle, E. L., Hanson, J. E., Gibb, J. W., & Hanson, G. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00588-9 · Cited by 134 · see citing works

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder

Roman, T., Szobot, C. M., Martins, S., Biederman, J., Rohde, L. A., & Hutz, M. H. (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00011 · Cited by 133 · see citing works

Cerebrospinal Fluid Homovanillic Acid Predicts Behavioral Response to Stimulants in 45 Boys with Attention Deficit/Hyperactivity Disorder

Castellanos, F. X., Elia, J., Kruesi, M. J. P., Marsh, W., Gulotta, C. S., Potter, W. Z., Ritchie, G. F., Hamburger, S. D., & Rapoport, J. L. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00077-q · Cited by 129 · see citing works

Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis

Seeman, P. M., & Madras, B. K. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00435-1 · Cited by 125 · see citing works

Methylphenidate Down-Regulates the Dopamine Receptor and Transporter System in Children with Attention Deficit Hyperkinetic Disorder (ADHD)

Vles, J. S. H., FERON, F. J. M., Hendriksen, J. G. M., Jolles, J., van Kroonenburgh, M. J. P. G., & Weber, W. E. J. (2003) · Neuropediatrics · doi:10.1055/s-2003-39602 · Cited by 122 · see citing works

Methylphenidate Redistributes Vesicular Monoamine Transporter-2: Role of Dopamine Receptors

Sandoval, V., Riddle, E. L., Hanson, G. R., & Fleckenstein, A. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08705.2002 · Cited by 121 · see citing works

Inhibitory Effects of Nitric Oxide on the Uptake of [3H]Dopamine and [3H]Glutamate by Striatal Synaptosomes

Lónárt, G., & Johnson, K. M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062108.x · Cited by 115 · see citing works

Structure‐activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates

Horn, A. S. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08331.x · Cited by 109 · see citing works

Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands

Gulley, J. M., & Zahniser, N. R. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.064 · Cited by 106 · see citing works

Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum

Brandon, C. L., & Steiner, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02892.x · Cited by 105 · see citing works

Greater Availability of Brain Dopamine Transporters in Major Depression Shown by [^99mTc]TRODAT-1 SPECT Imaging

Brunswick, D. J., Amsterdam, J. D., Mozley, P. D., & Newberg, A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1836 · Cited by 104 · see citing works

Serotonin 5-HT1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys

Frechilla, D., Cobreros, A., Saldise, L., Moratalla, R., Insausti, R., Luquín, M. R., & R�o, J. D. (2001) · Synapse · doi:10.1002/1098-2396(20010315)39:4 · Cited by 103 · see citing works

Psychoactive drugs in the immature organism

Kornetsky, C. H. (1970) · Psychopharmacology · doi:10.1007/bf00402703 · Cited by 100 · see citing works

The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample

CHEN, C.-K., Chen, S.-L., Mill, J. S., Huang, Y.-S., Lin, S.-K., Curran, S. R., Purcell, S., Sham, P. C., & Asherson, P. J. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001238 · Cited by 99 · see citing works

Association of Norepinephrine Transporter Gene With Methylphenidate Response

Yang, L., Wang, Y., Li, J., & Faraone, S. V. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000131134.63368.46 · Cited by 97 · see citing works

The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)

Madras, B. K., Miller, G. M., & Fischman, A. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00439-9 · Cited by 97 · see citing works

Intracellular Ca2+ Regulates Amphetamine-Induced Dopamine Efflux and Currents Mediated by the Human Dopamine Transporter

Gnegy, M. E., Khoshbouei, H., Berg, K. A., Javitch, J. A., Clarke, W. P., Zhang, M., & Galli, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.137 · Cited by 96 · see citing works

Dopamine transporter binding in Gilles de la Tourette syndrome

Müller-Vahl, K. R., Berding, G., Brücke, T., Kolbe, H., Meyer, G. J., Hundeshagen, H., Dengler, R., Knapp, W. H., & Emrich, H. M. (2000) · Journal of Neurology · doi:10.1007/pl00007806 · Cited by 95 · see citing works

Super-stereotypy I: Enhancement of a complex movement sequence by systemic dopamine D1 agonists

Berridge, K. C., & Aldridge, J. W. (2000) · Synapse · doi:10.1002/1098-2396(20000901)37:3 · Cited by 93 · see citing works

Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain

Canfield, D. R., Spealman, R. D., Kaufman, M. J., & Madras, B. K. (1990) · Synapse · doi:10.1002/syn.890060211 · Cited by 91 · see citing works

Alpha2‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex

Devoto, P., Flore, G., Pira, L., Longu, G., & Gessa, G. L. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02239.x · Cited by 88 · see citing works

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

Wilens, T. E. (2003) · Drugs · doi:10.2165/00003495-200363220-00002 · Cited by 86 · see citing works

Functional expression of the norepinephrine transporter in cultured rat astrocytes

Inazu, M., Takeda, H., & Matsumiya, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01514.x · Cited by 86 · see citing works

Phenylethylaminergic mechanisms in attention-deficit disorder

Baker, G. B., Bornstein, R. A., Rouget, A. C., Ashton, S., Muyden, J. C. V., & Coutts, R. T. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90207-3 · Cited by 84 · see citing works

Novel treatments for attention-deficit/hyperactivity disorder in children.

Spencer, T. J., Biederman, J., Wilens, T. E., & Faraone, S. V. (2002) · PubMed · Cited by 83 · see citing works

Stimulant drug treatment of hyperactivity: Biochemical correlates

Elia, J., Borcherding, B. G., Potter, W. Z., Mefford, I. N., Rapoport, J. L., & Keysor, C. S. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.118 · Cited by 83 · see citing works

No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins

Todd, R. D., Jong, Y.-J. I., Lobos, E. A., Reich, W., Heath, A. C., & Neuman, R. J. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1611 · Cited by 77 · see citing works

No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample

Palmer, C. G. S., Bailey, J. N., Ramsey, C., Cantwell, D. P., Sinsheimer, J. S., Del’Homme, M., McGough, J. J., Woodward, J. A., Asarnow, R. F., Asarnow, J. R., et al. (1999) · Psychiatric Genetics · doi:10.1097/00041444-199909000-00009 · Cited by 76 · see citing works

Inhibition of [3H]dopamine accumulation in rat striatal synaptosomes by psychotropic drugs

Hyttel, J. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90159-4 · Cited by 72 · see citing works

Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine

Izenwasser, S., Coy, A. E., Ladenheim, B., Loeloff, R. J., Cadet, J. L., & French, D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00274-5 · Cited by 69 · see citing works

Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway

Zhang, L., & Reith, M. E. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00646-2 · Cited by 65 · see citing works

Inhibition of mouse brain monoamine oxidase by (+)-amphetaminein vivo

Green, A. L., & Hait, M. A. S. E. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13223.x · Cited by 64 · see citing works

Differences between d -methamphetamine and d -amphetamine in rats: working memory, tolerance, and extinction

Shoblock, J. R., Maisonneuve, I. M., & Glick, S. D. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1522-y · Cited by 64 · see citing works

Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder

Spencer, T. J., & Biederman, J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s13 · Cited by 62 · see citing works

Variation of variable number of tandem repeat sequences in the 3′-untranslated region of primate dopamine transporter genes that affects reporter gene expression

Inoue‐Murayama, M., Adachi, S., Mishima, N., Mitani, H., Takenaka, O., Terao, K., Hayasaka, I., Ito, S., & Murayama, Y. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01125-4 · Cited by 61 · see citing works

Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children

Safer, D. J., & Allen, R. P. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80759-0 · Cited by 59 · see citing works

Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action

Ruskin, D. N., Bergstrom, D. A., Shenker, A., Freeman, L. E., Baek, D., & Walters, J. R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00987-2 · Cited by 57 · see citing works

No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study

Stamenkovic, M., Schindler, S. D., Asenbaum, S., Neumeister, A., Willeit, M., Willinger, U., de Zwaan, M., Riederer, F., Aschauer, H. N., & Kasper, S. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00134-6 · Cited by 52 · see citing works

Increased urine phenylethylamine after methylphenidate treatment in children with ADHD

Kusaga, A., Yamashita, Y., Koeda, T., Hiratani, M., Kaneko, M., Yamada, S., & Matsuishi, T. (2002) · Annals of Neurology · doi:10.1002/ana.10302 · Cited by 52 · see citing works

Organization of the projections from the pericruciate cortex to the pontomedullary reticular formation of the cat: A quantitative retrograde tracing study

Rho, M.-J., Cabana, T., & Drew, T. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971117)388:2 · Cited by 50 · see citing works

Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity

Roubert, C., Cox, P. J., Brüss, M., Hamon, M., Bönisch, H., & Bruno Giros, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009798200 · Cited by 49 · see citing works

Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats

Chase, T. D., Brown, R. E., CARREY, N. J., & Wilkinson, M. (2003) · Neuroreport · doi:10.1097/00001756-200304150-00022 · Cited by 48 · see citing works

A Pharmacokinetic/Pharmacodynamic Study Comparing a Single Morning Dose of Adderall to Twice-Daily Dosing in Children With ADHD

Greenhill, L. L., SWANSON, J. M., Steinhoff, K., FRIED, J., Posner, K., Lerner, M., Wigal, S. B., Clausen, S., Zhang, Y., & Tulloch, S. J. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200310000-00015 · Cited by 47 · see citing works

Ethanol potentiates the function of the human dopamine transporter expressed inXenopusoocytes

Mayfield, R. D., Maiya, R., Keller, D., & Zahniser, N. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00656.x · Cited by 45 · see citing works

Phenylethylamine Excretion in Attention Deficit Disorder

Zametkin, A. J., Karoum, F., Rapoport, J. L., Brown, G. L., & Wyatt, R. J. (1984) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60509-4 · Cited by 44 · see citing works

Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders

Miller, G. M., Garza, R. D. L., Novak, M. A., & Madras, B. K. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000809 · Cited by 44 · see citing works

The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample

Rubie, C., Schmidt, F., Knapp, M., Sprandel, J., Wiegand, C., Meyer, J., Jungkunz, G., Riederer, P. F., & Stöber, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01685-2 · Cited by 42 · see citing works

Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain

Gehlert, D. R., Schober, D. A., Hemrick-Luecke, S. K., Krushinski, J. H., Howbert, J. J., Robertson, D. W., Fuller, R. W., & Wong, D. T. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00113-9 · Cited by 37 · see citing works

Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76

Kimmel, H. L., Carroll, F. I., & Kuhar, M. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00160-4 · Cited by 37 · see citing works

Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys

Shekim, W. O., Javaid, J. I., Dekirmenjian, H., Chapel, J. L., & Davis, J. M. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.4.485 · Cited by 37 · see citing works

Differential Interactions of Desipramine with Amphetamine and Methamphetamine: Evidence that Amphetamine Releases Dopamine from Noradrenergic Neurons in the Medial Prefrontal Cortex

Shoblock, J. R., Maisonneuve, I. M., & Glick, S. D. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000026409.76261.f3 · Cited by 35 · see citing works

Alterations in Vesicular Dopamine Uptake Contribute to Tolerance to the Neurotoxic Effects of Methamphetamine

Johnson‐Davis, K. L., Truong, J. G., Fleckenstein, A. E., & Wilkins, D. G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062695 · Cited by 32 · see citing works

Catecholamine uptake sites in mouse brain: distribution determined by quantitative [3H]mazindol autoradiography

Donnan, G. A., Kaczmarczyk, S. J., McKenzie, J. S., Kalnins, R. M., Chilco, P. J., & Mendelsohn, F. A. O. (1989) · Brain Research · doi:10.1016/0006-8993(89)91598-9 · Cited by 31 · see citing works

Dopamine transporter‐dependent induction of C‐Fos in HEK cells

Yatin, S. M., Miller, G. M., Norton, C., & Madras, B. K. (2002) · Synapse · doi:10.1002/syn.10084 · Cited by 27 · see citing works

Attention deficit and hyperactivity disorder: review of genetic association studies.

Galili‐Weisstub, E., & Segman, R. H. (2003) · PubMed · Cited by 27 · see citing works

Dopamine Transporter Genotype Influences the Attention Deficit in Korean Boys with ADHD

Oh, K., Shin, D. W., Oh, G. T., & Noh, K. S. (2003) · Yonsei Medical Journal · doi:10.3349/ymj.2003.44.5.787 · Cited by 24 · see citing works

Treatment of ADHD When Tolerance to Methylphenidate Develops

Ross, D. C., Fischhoff, J., & Davenport, B. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.102 · Cited by 23 · see citing works

Efficacy of Adderall and Methylphenidate in Attention Deficit Hyperactivity Disorder: A Reanalysis Using Drug–Placebo and Drug–Drug Response Curve Methodology

Faraone, S. V., Pliszka, S. R., Olvera, R. L., Skolnik, R., & Biederman, J. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750284081 · Cited by 21 · see citing works

[Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder].

Qian, Q., Wang, Y., Li, J., Yang, L., Wang, B., & Zhou, R. (2003) · PubMed · Cited by 20 · see citing works

Störungen der Aufmerksamkeit und Aktivität (ADHS)

Schwemmle, C., Schwemmle, U., & Ptok, M. (2007) · HNO · doi:10.1007/s00106-007-1564-2 · Cited by 19 · see citing works

Attention deficit hyperactivity disorder

Tucker, S. M. (1999) · Journal of the Royal Society of Medicine · doi:10.1177/014107689909200501 · Cited by 18 · see citing works

Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder

Zametkin, A. J., Brown, G. L., Karoum, F., Rapoport, J., Langer, D. H., Chuang, L., & Wyatt, R. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.9.1055 · Cited by 12 · see citing works

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073 · see citing works

Neurobiology of ADHD

Tripp, G., & Wickens, J. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.026 · Cited by 492 · see citing works

Measured Gene-Environment Interactions in Psychopathology: Concepts, Research Strategies, and Implications for Research, Intervention, and Public Understanding of Genetics

Moffitt, T. E., Caspi, A., & Rutter, M. (2006) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2006.00002.x · Cited by 389 · see citing works

Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention?

Sonuga‐Barke, E. J. S., & Halperin, J. M. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02195.x · Cited by 320 · see citing works

Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works

Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders

Bloch, M. H., Panza, K. E., Landeros-Weisenberger, A., & Leckman, J. F. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b26e9f · Cited by 270 · see citing works

Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder

Wilens, T. E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173312f · Cited by 269 · see citing works

Potential Adverse Effects of Amphetamine Treatment on Brain and Behavior: A Review

Arcos-Burgos, M., Jain, M., Acosta, M. T., Shively, S., Stanescu, H., Wallis, D., Domené, S., Velez, J. I., Karkera, J., Balog, J. Z., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.90 · Cited by 423 · see citing works

Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis

Fusar-Poli, P., Rubia, K., Rossi, G., Sartori, G., & Balottin, U. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11060940 · Cited by 260 · see citing works

Dissociation in performance of children with ADHD and high-functioning autism on a task of sustained attention

Johnson, K. A., Robertson, I. H., Kelly, S. P., Silk, T. J., Barry, E., Dáibhis, A., Watchorn, A., Keavey, M., Fitzgerald, M., Gallagher, L., et al. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.02.019 · Cited by 259 · see citing works

Abuse of Amphetamines and Structural Abnormalities in the Brain

Berman, S. M., O’Neill, J., Fears, S. C., Bartzokis, G., & London, E. D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.031 · Cited by 253 · see citing works

Brain dopamine transporter levels in treatment and drug naive adults with ADHD

Volkow, N. D., Wang, G.-J., Newcorn, J., Fowler, J. S., Telang, F., Solanto, M. V., Logan, J., Wong, C., Ma, Y., Swanson, J. M., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.014 · Cited by 249 · see citing works

Attention-deficit-hyperactivity disorder and reward deficiency syndrome

Oscar Berman, M., Blum, K., Chen, T. J., Braverman, E., Waite, R., Downs, W., Arcuri, V., Notaro, A., Palomo, T., & Comings (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2627 · Cited by 248 · see citing works

Fetal programming of hypothalamic–pituitary–adrenal (HPA) axis function and behavior by synthetic glucocorticoids

Kapoor, A., Sophie Petropoulos, A., & Matthews, S. G. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.013 · Cited by 249 · see citing works

Neurocomputational models of basal ganglia function in learning, memory and choice

Cohen, M. X., & Frank, M. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.029 · Cited by 238 · see citing works

Clinically Relevant Doses of Methylphenidate Significantly Occupy Norepinephrine Transporters in Humans In Vivo

Hannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236 · see citing works

Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder

Frank, M. J., Santamaria, A., O'Reilly, R. C., & Willcutt, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301278 · Cited by 227 · see citing works

Smoking, nicotine and neuropsychiatric disorders

Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works

The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities

Carpenter, W. T., & Koenig, J. I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301639 · Cited by 210 · see citing works

Stimulus-dependent dopamine release in attention-deficit/hyperactivity disorder.

Sikström, S., & Söderlund, G. (2007) · Psychological Review · doi:10.1037/0033-295x.114.4.1047 · Cited by 205 · see citing works

Catecholamine Dysfunction in Attention-Deficit/Hyperactivity Disorder

Prince, J. B. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318174f92a · Cited by 207 · see citing works

Multidisciplinary perspectives on attention and the development of self-regulation

Berger, A., Kofman, O., Livneh, U., & Henik, A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.004 · Cited by 199 · see citing works

Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task

Bush, G., Spencer, T. J., Holmes, J., Shin, L. M., Valera, E. M., Seidman, L. J., Makris, N., Surman, C., Aleardi, M., Mick, E., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.16 · Cited by 201 · see citing works

The effects of physical activity on attention deficit hyperactivity disorder symptoms: The evidence

Gapin, J. I., Labban, J. D., & Etnier, J. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.01.022 · Cited by 201 · see citing works

Dopamine transporters govern diurnal variation in extracellular dopamine tone

Ferris, M. J., España, R. A., Locke, J. L., Konstantopoulos, J. K., Rose, J. H., Chen, R., & Jones, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407935111 · Cited by 192 · see citing works

Neurogenetics and Pharmacology of Learning, Motivation, and Cognition

Frank, M. J., & Fossella, J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.96 · Cited by 191 · see citing works

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

Moreau, C., Delval, A., Defebvre, L., Dujardin, K., Duhamel, A., Petyt, G., Vuillaume, I., Corvol, J., Brefel‐Courbon, C., Ory‐Magne, F., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70106-0 · Cited by 191 · see citing works

Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?

Bozzi, Y., & Borrelli, E. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.002 · Cited by 187 · see citing works

In Vivo Neuroreceptor Imaging in Attention-Deficit/Hyperactivity Disorder: A Focus on The Dopamine Transporter

Spencer, T. J., Biederman, J., Madras, B. K., Faraone, S. V., Dougherty, D. D., Bonab, A. A., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.036 · Cited by 185 · see citing works

Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter

Salahpour, A., Ramsey, A., Medvedev, I., Kile, B. M., Sotnikova, T. D., Holmstrand, E., Ghisi, V., Nicholls, P., Wong, L., Murphy, K. L., et al. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0707646105 · Cited by 189 · see citing works

Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD

Franke, B., Vasquez, A. A., Johansson, S., Hoogman, M., Romanos, J., Boreatti-Hümmer, A., Heine, M., Jacob, C. P., Lesch, K.-P., Casas, M., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.170 · Cited by 183 · see citing works

Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects

Caldú, X., Vendrell, P., David Bartrés-faz, A., Clemente, I. C., Bargalló, N., Jurado, M. Á., Serra-Grabulosa, J. M., & Junqué, C. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.06.021 · Cited by 183 · see citing works

Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder

Buske-Kirschbaum, A., Schmitt, J., Plessow, F., Romanos, M., Weidinger, S., & Roessner, V. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.017 · Cited by 179 · see citing works

Morphological Abnormalities of the Thalamus in Youths With Attention Deficit Hyperactivity Disorder

Ivanov, I., Bansal, R., Hao, X., Zhu, H., Kellendonk, C., Miller, L., Sanchez-Pena, J., Miller, A. M., Chakravarty, M. M., Klahr, K., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030398 · Cited by 172 · see citing works

Association of pyrethroid pesticide exposure with attention-deficit/hyperactivity disorder in a nationally representative sample of U.S. children

Wagner-Schuman, M. L., Richardson, J. R., Auinger, P., Braun, J. M., Lanphear, B. P., Epstein, J. N., Yolton, K. A., & Froehlich, T. E. (2015) · Environmental Health · doi:10.1186/s12940-015-0030-y · Cited by 162 · see citing works

Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease

Devos, D., Krystkowiak, P. C., Clement, F., Dujardin, K., Cottencin, O., Waucquier, N., Ajebbar, K., Thielemans, B., Kroumova, M., Duhamel, A., et al. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.100016 · Cited by 153 · see citing works

Regulation of monoamine transporters: Role of transporter phosphorylation

Ramamoorthy, S., Shippenberg, T. S., & Jayanthi, L. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.009 · Cited by 151 · see citing works

A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview

Chen, J., Férec, C., & Cooper, D. N. (2006) · Human Genetics · doi:10.1007/s00439-006-0180-7 · Cited by 147 · see citing works

Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder

Richardson, J., Taylor, M. M., Shalat, S., Guillot, T., Caudle, W., Hossain, M. M., Mathews, T. A., Jones, S. R., Cory-Slechta, D., & Miller, G. (2015) · The FASEB Journal · doi:10.1096/fj.14-260901 · Cited by 132 · see citing works

The Placental Barrier: the Gate and the Fate in Drug Distribution

Tetro, N., Moushaev, S., Rubinchik-Stern, M., & Eyal, S. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2286-0 · Cited by 145 · see citing works

Does the difference between physically active and couch potato lie in the dopamine system?

Knab, A. M., & Lightfoot, J. T. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.133 · Cited by 140 · see citing works

Control of Extracellular Dopamine at Dendrite and Axon Terminals

Ford, C., Gantz, S. C., Phillips, P. E. M., & Williams, J. T. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1020-10.2010 · Cited by 135 · see citing works

Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels

Kern, C. H., Stanwood, G. D., & Smith, D. R. (2009) · Synapse · doi:10.1002/syn.20736 · Cited by 134 · see citing works

Development and function of the midbrain dopamine system: what we know and what we need to

Bissonette, G. B., & Roesch, M. R. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12257 · Cited by 133 · see citing works

Low-Level Human Equivalent Gestational Lead Exposure Produces Sex-Specific Motor and Coordination Abnormalities and Late-Onset Obesity in Year-Old Mice

Leasure, J. L., Giddabasappa, A., Chaney, S., Johnson, J. E., Pothakos, K., Lau, Y., & Fox, D. A. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10862 · Cited by 128 · see citing works

Dimensional Analysis of ADHD Subtypes in Rats

Blondeau, C., & Dellu-Hagedorn, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.030 · Cited by 126 · see citing works

Attention deficit/hyperactivity disorder: a focused overview for children’s environmental health researchers

Aguiar, A., Eubig, P. A., & Schantz, S. L. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002326 · Cited by 125 · see citing works

Early life protein restriction alters dopamine circuitry

Vucetic, Z., Totoki, K., Schoch, H., Whitaker, K. W., Hill‐Smith, T. E., Lucki, I., & Reyes, T. M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.010 · Cited by 119 · see citing works

Caffeine Regulates Frontocorticostriatal Dopamine Transporter Density and Improves Attention and Cognitive Deficits in an Animal Model of Attention Deficit Hyperactivity Disorder

Pandolfo, P., Machado, N. J., Köfalvi, A., Takahashi, R. N., & Cunha, R. A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.011 · Cited by 118 · see citing works

Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease

Devos, D., Defebvre, L., & Bordet, R. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00798.x · Cited by 117 · see citing works

History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia

Madras, B. K. (2013) · Journal of the History of the Neurosciences · doi:10.1080/0964704x.2012.678199 · Cited by 116 · see citing works

Origins of altered reinforcement effects in ADHD

Johansen, E., Killeen, P. R., Russell, V. A., Tripp, G., Wickens, J. R., Tannock, R., Williams, J., & Sagvolden, T. (2009) · Behavioral and Brain Functions · doi:10.1186/1744-9081-5-7 · Cited by 108 · see citing works

Methylphenidate improves deficient error evaluation in children with ADHD; an event-related brain potential study

Jonkman, L. M., van Melis, J. J. M., Kemner, C., & Markus, C. R. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2007.08.004 · Cited by 111 · see citing works

An atlas of transcriptionally defined cell populations in the rat ventral tegmental area

Phillips, R. A., Tuscher, J. J., Black, S. L., Andraka, E., Fitzgerald, N. D., Ianov, L., & Day, J. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110616 · Cited by 114 · see citing works

SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder

Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110 · see citing works

A Comprehensive <i>In Vitro</i> Screening of <i>d-, l-</i> , and <i>dl-threo</i> -Methylphenidate: An Exploratory Study

Markowitz, J. S., DeVane, C. L., Pestreich, L. K., Patrick, K. S., & Muniz, R. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.687 · Cited by 109 · see citing works

Review of Rodent Models of Attention Deficit Hyperactivity Disorder

Regan, S. L., Williams, M. T., & Vorhees, C. (2021) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.041 · Cited by 96 · see citing works

Prediction of Heterogeneity in Intelligence and Adult Prognosis by Genetic Polymorphisms in the Dopamine System Among Children With Attention-Deficit/Hyperactivity Disorder

Mill, J. S., Caspi, A., Williams, B. S., Craig, I., Taylor, A., Polo-Tomás, M., Berridge, C. W., Poulton, R., & Moffitt, T. E. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.462 · Cited by 102 · see citing works

Increased impulsive behavior and risk proneness following lentivirus-mediated dopamine transporter over-expression in rats' nucleus accumbens

Adriani, W., Boyer, F., Gioiosa, L., Macrì, S., Dreyer, J.-L., & Laviola, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.042 · Cited by 97 · see citing works

Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety

Zafeiri, A., Mitchell, R. T., Hay, D. C., & Fowler, P. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa042 · Cited by 100 · see citing works

Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: Current status and working hypotheses

Vaidya, C. J., & Stollstorff, M. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.40 · Cited by 95 · see citing works

Smoking during pregnancy and hyperactivity-inattention in the offspring--comparing results from three Nordic cohorts

Obel, C., Línnet, K., Henriksen, T. B., Rodriguez, A., Järvelin, M., Kotimaa, A., Moilanen, I. K., Ebeling, H., Bilenberg, N., Taanila, A. M., et al. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym290 · Cited by 95 · see citing works

Electrophysiological evidence of atypical motivation and reward processing in children with attention-deficit hyperactivity disorder

Holroyd, C. B., Baker, T. E., Kerns, K. A., & Müller, U. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.02.011 · Cited by 92 · see citing works

Epigenetics in Developmental Disorder: ADHD and Endophenotypes

Archer, T., & Oscar‐Berman, M. (2011) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000104 · Cited by 92 · see citing works

Altered dopaminergic profiles: Implications for the regulation of voluntary physical activity

Knab, A. M., Bowen, R. S., Hamilton, A., Gulledge, A. A., & Lightfoot, J. T. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.034 · Cited by 91 · see citing works

Handbook of Reward and Decision Making

Dreher, J., & Tremblay, L. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374620-7.x0001-5 · Cited by 88 · see citing works

Coffee consumption during pregnancy and the risk of hyperkinetic disorder and ADHD: a prospective cohort study

Linnet, K. M., Wisborg, K., Secher, N. J., Hove Thomsen, P., Obel, C., Dalsgaard, S., & Henriksen, T. B. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00980.x · Cited by 87 · see citing works

Trace Amine-Associated Receptor 1 Displays Species-Dependent Stereoselectivity for Isomers of Methamphetamine, Amphetamine, and Para-Hydroxyamphetamine

Reese, E. A., Bunzow, J. R., Arttamangkul, S., Sonders, M. S., & Grandy, D. K. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115402 · Cited by 85 · see citing works

Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD

Krause, J., la Fougere, C., Krause, K.-H., Ackenheil, M., & Dresel, S. H. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0602-x · Cited by 84 · see citing works

Transgenic mouse models for ADHD

Leo, D., & Gainetdinov, R. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1639-1 · Cited by 74 · see citing works

ADHD related behaviors are associated with brain activation in the reward system

Stark, R., Bauer, E., Merz, C. J., Zimmermann, M., Reuter, M., Plichta, M. M., Kirsch, P., Lesch, K. P., Fallgatter, A. J., Vaitl, D., et al. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.12.012 · Cited by 82 · see citing works

The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics

Boswell, R. G., Potenza, M. N., & Grilo, C. M. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.10.014 · Cited by 82 · see citing works

Association and linkage of allelic variants of the dopamine transporter gene in ADHD

Friedel, S., Saar, K., Sauer, S., Dempfle, A., Walitza, S., Renner, T., Romanos, M., Freitag, C. M., Seitz, C., Pálmason, H., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001986 · Cited by 80 · see citing works

Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood

Nemoda, Z., Szekely, A., & Sasvari-Szekely, M. (2011) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.002 · Cited by 78 · see citing works

Association of the dopamine transporter (<i>SLC6A3/DAT1</i>) gene 9–6 haplotype with adult ADHD

Franke, B., Hoogman, M., Arias Vasquez, A., Heister, J. G. A. M., Savelkoul, P. J., Naber, M., Scheffer, H., Kiemeney, L. A., Kan, C. C., Kooij, J. J. S., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30861 · Cited by 77 · see citing works

Social Behavior and Skills in Children

Matson, J. L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0234-4 · Cited by 75 · see citing works

Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling

Duchesne, A., Dufresne, M. M., & Sullivan, R. M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.012 · Cited by 75 · see citing works

Differential Pharmacokinetics and Pharmacodynamics of Methylphenidate Enantiomers

Markowitz, J. S., & Patrick, K. S. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181733560 · Cited by 74 · see citing works

The dopamine transporter role in psychiatric phenotypes

Salatino‐Oliveira, A., Rohde, L. A., & Hutz, M. H. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32578 · Cited by 72 · see citing works

Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression

Calipari, E. S., Ferris, M. J., Salahpour, A., Caron, M. G., & Jones, S. R. (2013) · Nature Communications · doi:10.1038/ncomms3720 · Cited by 72 · see citing works

Food allergy and food‐based therapies in neurodevelopmental disorders

de Theije, C. G. M., Bavelaar, B. M., da Silva, S. L., Korte, S. M., Olivier, B., Garssen, J., & Kraneveld, A. D. (2013) · Pediatric Allergy and Immunology · doi:10.1111/pai.12149 · Cited by 71 · see citing works

Sex differences in attentional processes in adult rats as measured by performance on the 5-choice serial reaction time task

Bayless, D. W., Darling, J. S., Stout, W. J., & Daniel, J. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.028 · Cited by 71 · see citing works

Effects of Ethanol Exposure During Early Pregnancy in Hyperactive, Inattentive and Impulsive Behaviors and MeCP2 Expression in Rodent Offspring

Kim, P., Park, J., Choi, C. S., Choi, I., Joo, S. H., Kim, M. K., Kim, S. Y., Kim, K. C., Park, S. H., Kwon, K. J., et al. (2013) · Neurochemical Research · doi:10.1007/s11064-012-0960-5 · Cited by 71 · see citing works

Causal Factors of Increased Smoking in ADHD: A Systematic Review

van Amsterdam, J., van der Velde, B., Schulte, M., & van den Brink, W. (2018) · Substance Use & Misuse · doi:10.1080/10826084.2017.1334066 · Cited by 63 · see citing works

Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry

Daumann, J., Koester, P., Becker, B., Wagner, D. R., Imperati, D., Gouzoulis‐Mayfrank, E., & Tittgemeyer, M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.08.065 · Cited by 71 · see citing works

The Structure and Function of the Dopamine Transporter and its Role in CNS Diseases

McHugh, P., & Buckley, D. A. (2015) · Vitamins and hormones · doi:10.1016/bs.vh.2014.12.009 · Cited by 69 · see citing works

Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder

Hesse, S., Ballaschke, O., Barthel, H., & Sabri, O. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.01.002 · Cited by 69 · see citing works

Does environmental exposure to the greenhouse gas, N 2 O, contribute to etiological factors in neurodevelopmental disorders? A mini-review of the evidence

Fluegge, K. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.08.013 · Cited by 67 · see citing works

SUICIDE RISK IN ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Giupponi, G., Giordano, G., Maniscalco, I., Erbuto, D., Berardelli, I., Conca, A., Lester, D., Girardi, P., & Pompili, M. (2018) · Psychiatria Danubina · doi:10.24869/psyd.2018.2 · Cited by 64 · see citing works

A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients

Joyce, P. R., McHugh, P., McKenzie, J. M., Sullivan, P. F., Mulder, R., Luty, S. E., Carter, J. D., FRAMPTON, C. M. A., Cloninger, C. R., MILLER, A. M., et al. (2006) · Psychological Medicine · doi:10.1017/s0033291706007288 · Cited by 64 · see citing works

A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD

Rommelse, N., Altink, M., Arias-Vásquez, A., Buschgens, C., Fliers, E., Faraone, S., Buitelaar, J., Sergeant, J., Franke, B., & Oosterlaan, J. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30848 · Cited by 64 · see citing works

ADHD and hyperkinetic disorder

Sonuga‐Barke, E. J. S., & Taylor, E. (2015) · Rutter's Child and Adolescent Psychiatry · doi:10.1002/9781118381953.ch55 · Cited by 62 · see citing works

The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens

Miller, E. M., Pomerleau, F., Huettl, P. F., Russell, V. A., Gerhardt, G. A., & Glaser, P. E. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.020 · Cited by 62 · see citing works

Hyperactivity in the rat is associated with spontaneous low level of n-3 polyunsaturated fatty acids in the frontal cortex

Vancassel, S., Blondeau, C., Lallemand, S.-M., Cador, M., Linard, A., Lavialle, M., & Dellu-Hagedorn, F. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.032 · Cited by 61 · see citing works

Resting-State Striato-Frontal Functional Connectivity is Sensitive to DAT1 Genotype and Predicts Executive Function

Gordon, E. M., Devaney, J. M., Bean, S. E., & Vaidya, C. J. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht229 · Cited by 60 · see citing works

Differentiating Physicochemical Properties between Addictive and Nonaddictive ADHD Drugs Revealed by Molecular Dynamics Simulation Studies

Wang, P., Zhang, X., Fu, T., Li, S., Li, B., Xue, W., Yao, X., Chen, Y., & Zhu, F. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00173 · Cited by 60 · see citing works

Positron emission tomography neuroimaging for a better understanding of the biology of ADHD

Zimmer, L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.001 · Cited by 60 · see citing works

LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy.

Choudhry, Z., Sengupta, S. M., Grizenko, N., Fortier, M., Thakur, G. A., Bellingham, J., & Joober, R. (2012) · Journal of Child Psychology and Psychiatry and Allied Disciplines · doi:10.1111/j.1469-7610.2012.02551.x · Cited by 58 · see citing works

Effect of Dopamine Transporter Gene (SLC6A3) Variation on Dorsal Anterior Cingulate Function in Attention-Deficit/Hyperactivity Disorder

Brown, A. B., Biederman, J., Valera, E. M., Doyle, A., Bush, G., Spencer, T., Monuteaux, M., Mick, E., Whitfield-Gabrieli, S., Makris, N., et al. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31022 · Cited by 53 · see citing works

Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder

Lepping, P., & Huber, M. K. (2010) · CNS Drugs · doi:10.2165/11537610-000000000-00000 · Cited by 55 · see citing works

ADHD and the Dopamine Transporter: Are There Reasons to Pay Attention?

Mazei‐Robison, M. S., & Blakely, R. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_17 · Cited by 33 · see citing works

The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)

Madras, B. K., Miller, G. M., & Fischman, A. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00439-9 · Cited by 97 · see citing works

The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder

Krause, K.-H., Dresel, S. H. J., Krause, J., la Fougère, C. J., & Ackenheil, M. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.012 · Cited by 181 · see citing works

Dopamintransporter - Struktur, Funktion und Bedeutung für die ADHS

Krause, K., & Krause, J. (2006) · psychoneuro · doi:10.1055/s-2006-942778 · Cited by 6 · see citing works

SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder

Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110 · see citing works